190 related articles for article (PubMed ID: 27115606)
1. Hepatitis C Virus Protein Interaction Network Analysis Based on Hepatocellular Carcinoma.
Han Y; Niu J; Wang D; Li Y
PLoS One; 2016; 11(4):e0153882. PubMed ID: 27115606
[TBL] [Abstract][Full Text] [Related]
2. Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis.
Park CY; Choi SH; Kang SM; Kang JI; Ahn BY; Kim H; Jung G; Choi KY; Hwang SB
J Hepatol; 2009 Nov; 51(5):853-64. PubMed ID: 19726098
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis.
Parvaiz F; Manzoor S; Iqbal J; Sarkar-Dutta M; Imran M; Waris G
World J Gastroenterol; 2015 Nov; 21(43):12361-9. PubMed ID: 26604643
[TBL] [Abstract][Full Text] [Related]
4. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes.
Iqbal J; McRae S; Banaudha K; Mai T; Waris G
J Biol Chem; 2013 Dec; 288(52):36994-7009. PubMed ID: 24240095
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells.
Liu J; Ding X; Tang J; Cao Y; Hu P; Zhou F; Shan X; Cai X; Chen Q; Ling N; Zhang B; Bi Y; Chen K; Ren H; Huang A; He TC; Tang N
PLoS One; 2011; 6(11):e27496. PubMed ID: 22110662
[TBL] [Abstract][Full Text] [Related]
7. Phospho-Network Analysis Identifies and Quantifies Hepatitis C Virus (HCV)-induced Hepatocellular Carcinoma (HCC) Proteins Regulating Viral-mediated Tumor Growth.
Lu NT; Liu NM; Vu JQ; Patel D; Cohn W; Capri J; Ziegler M; Patel N; Tramontano A; Williams R; Whitelegge J; French SW
Cancer Genomics Proteomics; 2016 09-10; 13(5):339-57. PubMed ID: 27566653
[TBL] [Abstract][Full Text] [Related]
8. Alterations of Wnt/β-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis C virus.
Rogacki K; Kasprzak A; Stępiński A
Pol J Pathol; 2015 Mar; 66(1):9-21. PubMed ID: 26017875
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C virus infected HCC.
Yuan W; Huang T; Yu J; Zeng L; Lian B; He Q; Li Y; Zhang X; Zhou F; Xie L
Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):271-9. PubMed ID: 23774196
[TBL] [Abstract][Full Text] [Related]
10. Lectin BS-I inhibits cell migration and invasion via AKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma.
Jian Q; Yang Z; Shu J; Liu X; Zhang J; Li Z
J Cell Mol Med; 2018 Jan; 22(1):315-329. PubMed ID: 28922551
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus-induced activation of β-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events.
Higgs MR; Lerat H; Pawlotsky JM
Oncogene; 2013 Sep; 32(39):4683-93. PubMed ID: 23108410
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated PLAC8 promotes hepatocellular carcinoma cell proliferation by enhancing PI3K/Akt/GSK3β/Wnt/β-catenin signaling.
Zou L; Chai J; Gao Y; Guan J; Liu Q; Du JJ
Biomed Pharmacother; 2016 Dec; 84():139-146. PubMed ID: 27643556
[TBL] [Abstract][Full Text] [Related]
13. HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.
Chen Z; Tang J; Cai X; Huang Y; Gao Q; Liang L; Tian L; Yang Y; Zheng Y; Hu Y; Tang N
Cancer Sci; 2016 Oct; 107(10):1380-1389. PubMed ID: 27420729
[TBL] [Abstract][Full Text] [Related]
14. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C-associated liver carcinogenesis: role of PML nuclear bodies.
Herzer K; Gerken G; Hofmann TG
World J Gastroenterol; 2014 Sep; 20(35):12367-71. PubMed ID: 25253937
[TBL] [Abstract][Full Text] [Related]
16. Enhanced immune responses, PI3K/AKT and JAK/STAT signaling pathways following hepatitis C virus eradication by direct-acting antiviral therapy among Egyptian patients: a case control study.
Ramadan HK; Badr G; Ramadan NK; Sayed A
Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33524139
[TBL] [Abstract][Full Text] [Related]
17. Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases.
Yamaguchi T; Yoshida K; Murata M; Matsuzaki K
World J Gastroenterol; 2014 Sep; 20(35):12381-90. PubMed ID: 25253939
[TBL] [Abstract][Full Text] [Related]
18. Y-Box Binding Protein 1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate Viral Propagation.
Wang WT; Tsai TY; Chao CH; Lai BY; Wu Lee YH
J Virol; 2015 Nov; 89(22):11584-602. PubMed ID: 26355086
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response.
Wang Y; Jiang Y; Zhou J; Song W; Li J; Wang M; Chen J; Xu R; Zhang J; Ma F; Chen YH; Ma Y
Tumour Biol; 2016 Nov; 37(11):15265-15274. PubMed ID: 27696294
[TBL] [Abstract][Full Text] [Related]
20. The oncogenic role of NS5A of hepatitis C virus is mediated by up-regulation of survivin gene expression in the hepatocellular cell through p53 and NF-κB pathways.
Jiang YF; He B; Li NP; Ma J; Gong GZ; Zhang M
Cell Biol Int; 2011 Dec; 35(12):1225-32. PubMed ID: 21612579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
